Neha Alang and Colleen R. Kelly recently reported that a patient who had received fecal microbiota transplantation (FMT) developed obesity (1).
Dr. Faming Zhang, on treating refractory Crohn’s disease with fecal microbiota transplantation
12 Jan 2015by Kristina Campbell
Dr. Faming Zhang, MD, PhD, is a doctor and researcher at the Institute for Digestive Endoscopy & Medical Center for Digestive Diseases at The Second Affiliated Hospital of Nanjing Medical University in Nanjing, China. He is Vice Chief of the Medical Center for Digestive Diseases, and Director of Intestinal Diseases.
Prof. Stephan Schreiber is a physician, working as a gastroenterologist. He's also a director of the Clinic for Internal Medicine at Kiel Campus of the University Hospital Schleswig-Holstein in Germany. His main research focus has been the molecular etiology of
In a previous GMFH article, ‘PROBIOTICS’ PART I: A BRANCHING DEFINITION, we covered recent updates to the definition of probiotics as discussed at the October 2013 meeting organized by The International Scientific Association for Probiotics and Prebiotics (ISAPP). Three of
Interview with Dr. James Versalovic, children’s microbiome researcher
8 Sep 2014by Kristina Campbell
Dr. James Versalovic, M.D., Ph.D, is the director of the Texas Children's Hospital Microbiome Center and head of the Pediatric Infectious Diseases Section. He is also a professor at Baylor College of Medicine. As the Gut Microbiota for Health expert on research tools, Dr. Versalovic spoke with
A guide to the present and future of fecal microbiota transplantation, with Dr. Alexander Khoruts
1 Sep 2014by Kristina Campbell
Alexander Khoruts, MD, is a gastroenterologist and Associate Professor of Medicine at University of Minnesota. Since he carried out his first fecal microbiota transplantation (FMT) in 2008, he has conducted research on the procedure and developed protocols for wider clinical use.
Stein and colleagues describe in their study, published in PLOS computational biology, how time series can help to study dynamics of the microbiota. Moreover, unlike usual cross sectional studies which lack a mechanistic understanding of the ecosystem's structure and its
Using a stress model in animals, Da Silva and colleagues induced gut hyperpermeability and visceral hypersensitivity as well as a shift in O-glycosylation of mucins, associated with flattening and loss of the mucus layer cohesive properties. The probiotic L. farciminis
Lawrence and colleagues tracked two subjects' microbiota over a year, collecting 800 fecal and saliva samples associated with 10,000 longitudinal measurements. They first highlighted the evidence for long-term, overall community stability, as differences between individuals were much larger than variation within
In a study published in Cancer Prevention Research, Dr. Patrick Schloss (University of Michigan) and his team found that the gut microbiome could enrich current methods of testing for colon cancer. The group characterized the gut microbiome from stool samples of
